Engaging dystonia networks with subthalamic stimulation
Abstract
Deep brain stimulation is an efficacious treatment for dystonia. While the internal pallidum serves as the primary target, recently, stimulation of the subthalamic nucleus (STN) has been investigated. However, optimal targeting within this structure and its surroundings have not been studied in depth. Indeed, historical targets that have been used for surgical treatment of dystonia are directly adjacent to the STN. Further, multiple types of dystonia exist, and outcomes are variable, suggesting that not all types would profit maximally from the same target. Therefore, a thorough investigation of neural substrates underlying stimulation effects on dystonia signs and symptoms is warranted. Here, we analyze a multicenter cohort of isolated dystonia patients with subthalamic implantations ( N = 58) and relate their stimulation sites to improvements of appendicular and cervical symptoms as well as blepharospasm. Stimulation of the ventral oral posterior nucleus of thalamus and surrounding regions were associated with improvements in cervical dystonia, while stimulation of the dorsolateral STN was associated with improvements in limb dystonia and blepharospasm. This dissociation was matched by structural connectivity analysis, where the cerebellothalamic, corticospinal, and pallidosubthalamic tracts were associated with improvements of cervical dystonia, while hyperdirect and subthalamopallidal pathways with alleviation of limb dystonia and blepharospasm. On the level of functional networks, improvements of limb dystonia were associated with connectivity to the corresponding somatotopic regions in the primary motor cortex, while alleviation of cervical dystonia to the cingulo-opercular network. These findings shed light on the pathophysiology of dystonia and may guide DBS targeting and programming in the future.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (21)
Konstantin Butenko
Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School
Clemens Neudorfer
Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School
Till A. Dembek
Department of Neurology, Faculty of Medicine, University of Cologne
Barbara Hollunder
Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin
Garance M. Meyer
Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School
Ningfei Li
Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin
Simón Oxenford
Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin
Bahne H. Bahners
Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School
Bassam Al-Fatly
Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin
Roxanne Lofredi
Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin
Evan M. Gordon
Nico U. F. Dosenbach
Christos Ganos
Movement Disorder Clinic, Edmond J. Safra Program in Parkinson’s Disease, Division of Neurology, University of Toronto, Toronto Western Hospital
Mark Hallett
Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH
Hyder A. Jinnah
Department of Neurology, Emory University
Philip A. Starr
Jill L. Ostrem
Movement Disorders and Neuromodulation Centre, Department of Neurology, University of California
Yiwen Wu
Department of Neurology & Institute of Neurology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Chencheng Zhang
Michael D. Fox
Andreas Horn